Information on the Target

Cambridge GaN Devices (CGD) is a pioneering spinout from the University of Cambridge, specializing in the development of energy-efficient semiconductors based on gallium nitride (GaN). The company's mission is to transform the power electronics landscape, specifically targeting applications in electric vehicles and data centers. With its cutting-edge monolithic ICeGaN® technology, CGD is able to achieve impressive efficiency levels that exceed 99%, enabling significant energy savings and reducing CO2 emissions on a global scale.

CGD has recently completed a successful $32 million Series C funding round, with investments from notable firms including Parkwalk, British Patient Capital, BGF, Cambridge Innovation Capital (CIC), Foresight Group, and IQ Capital. This funding represents a critical step forward for CGD as it seeks to broaden its market presence and continue innovating within the power semiconductor sector.

Industry Overview in the Target’s Specific Country

The global power semiconductor industry is undergoing a significant transformation, especially with the increasing adoption of gallium nitride (GaN) technology. Projected to grow at a compound annual growth rate (CAGR) of 41%, the GaN power device market could reach a valuation of $2 billion by 2029. This growth is fueled by the need for more efficient and compact power solutions in various sectors, including automotive and data centers.

In the UK, the landscape for semiconductor innovation is continually evolving, supported by robust research initiatives and a strong commitment to sustainability. The advancements in GaN technology stand to offer a viable alternative to traditional silicon-based solutions while providing enhanced energy efficiency and reduced operational costs.

As more industries recognize the potential of GaN, companies like CGD find themselves in an advantageous position, targeting an estimated market exceeding $10 billion by 2029. This presents fertile ground for growth as companies embrace electrification and environmentally friendly practices.

Furthermore, the UK government’s focus on boosting the semiconductor sector, along with various funding initiatives, aims to propel the industry into global leadership, ensuring companies like CGD benefit significantly from expanding investment opportunities and market demands.

The Rationale Behind the Deal

The decision to invest in Cambridge GaN Devices stems from the growing demand for energy-efficient solutions across numerous high-power applications. With electric vehicles and data centers becoming increasingly prevalent, the need for advanced semiconductor technologies that meet sustainability goals is paramount. CGD’s innovative technology and its proven track record of high performance resonate strongly with investors looking to support environmentally friendly advancements.

By securing this funding, CGD is well-positioned to ramp up its production capabilities and expand into key markets such as North America, Europe, and Taiwan, thus reaffirming its commitment to innovation and growth within the power electronics sector.

Information About the Investor

Parkwalk Advisors, the lead investor in CGD's recent funding round, is renowned for its focus on deep tech investments. By supporting transformative technologies and companies with the potential for significant market impact, Parkwalk has established itself as a vital player in fostering innovation. John Pearson, the Chief Investment Officer at Parkwalk, stated that CGD has been at the forefront of reducing energy demands and is well-equipped to innovate within industries like Artificial Intelligence and Electric Mobility.

Other investors, including British Patient Capital and BGF, share a common vision of promoting sustainable technologies and contributing to the long-term growth of companies that prioritize environmental impact. Their collective support will enable CGD to scale operations and enhance its market position across various sectors.

View of Dealert

This investment in Cambridge GaN Devices represents a potentially lucrative opportunity for all involved stakeholders. CGD's innovative approach to gallium nitride technology aligns perfectly with the global push for energy efficiency and sustainability, making it an attractive prospect for investors. Given their growing client base and proven technology, CGD is primed for substantial growth in the coming years.

The projected CAGR of 41% for the GaN power device market certainly supports this investment, suggesting a favorable economic backdrop that could help CGD thrive. With institutions increasingly recognizing the advantages of GaN over traditional silicon technologies, CGD’s advanced products are likely to gain substantial traction across multiple industries.

Moreover, with CGD’s strategic growth plans and expanding geographical presence, investors can expect to see significant returns on their investment as the company continues to secure key customer agreements and innovate. Therefore, this deal appears to be a wise investment not just for the present, but also for the long-term sustainability of both CGD and its supporting partners.

View Original Article

Similar Deals

Northern Gritstone Pragmatic

2023

Other Semiconductors & Semiconductor Equipment United Kingdom
PragmatIC Semiconductor PragmatIC Semiconductor

Other Semiconductors & Semiconductor Equipment United Kingdom
Strategic Investor Cambridge GaN Devices (CGD)

Other Semiconductors & Semiconductor Equipment United Kingdom
British Patient Capital, In-Q-Tel Pragmatic

Other Semiconductors & Semiconductor Equipment United Kingdom
Athora PICG

2026

Other Insurance United Kingdom
Aryza RiskLogix Solutions Holdings Limited

2025

Other Software & IT Services United Kingdom
Acuity Knowledge Partners Ascent

2025

Other Software & IT Services United Kingdom
Blackstone AGS Airports

2025

Other Passenger Transportation Services United Kingdom
Stock Spirits Group The Drinks Company

2025

Other Beverages United Kingdom
Aspen Technology, Inc. Open Grid Systems Limited

2025

Other Professional & Commercial Services United Kingdom

Parkwalk

invested in

Cambridge GaN Devices (CGD)

in 2025

in a Other deal

Disclosed details

Transaction Size: $32M

Deal Parametres
Industry
Country
Seller type

Sign Up to Dealert